Immunome Inc.
IMNM
Revenue
2.36M
▲1.34M▲129.74%
3 Months ChangeAssets
296.22M
▼-23.54M▼-7.36%
3 Months ChangeLiabilities
42.38M
▲8.20M▲23.97%
3 Months ChangeFree Cash Flow
-13.33M
▼-37.40M▼-155.40%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-29
Form 8-K
ID: 0001104659-24-112053
2024-10-08
Form 8-K
ID: 0001104659-24-106777
2024-08-12
Form 10-Q
ID: 0001558370-24-011898
2024-08-12
Form 8-K
ID: 0001104659-24-088340
2024-06-13
Form 8-K
ID: 0001104659-24-071253
2024-05-14
Form 10-Q
ID: 0001558370-24-008066
2024-05-14
Form 8-K
ID: 0001104659-24-060893
2024-04-30
Form 8-K
ID: 0001104659-24-054910
2024-04-25
Form 8-K
ID: 0001104659-24-051944
2024-03-28
Form 8-K
ID: 0001104659-24-040503